The Sanger sequencing market was valued at USD 2.9 Billion in 2023 and is projected to reach USD 12.35 Billion by 2032, growing at a compound annual growth rate (CAGR) of 18.63% from 2024 to 2032.

454 Life Sciences Corporation has announced the launch of the new GS FLX Titanium series reagents and software that are transforming the life science’s industry. According to Company, the new reagent ...